Medline Overview
Latest ROE for Medline: 5.97% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow5.97%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, MDLN shows a ROE of 5.97%. That is above the sector sector average of -5.72%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about -5.72%. Medline is at 5.97%, which is higher that average. That is roughly 204.4% above the sector mean. Use the comparison chart on this page to see how MDLN stacks up against individual peers as well.
Check the historical chart to see whether MDLN's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Medline with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Medline's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 5.97%) with ownership activity and broader fundamentals.
